Aller au contenu principal
Accès ouvert déclaré 2026 article

Increased rates of surgical resection of early-stage small cell lung cancer in a single-institution cohort

1Citations signalées, ce qui n’est pas une note de qualité
2Institutions déclarées
1Pays d’affiliation déclarés

Rattachement africain : us. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

Background: Increasing chest imaging utilization, including for screening, identifies more non-small cell lung cancer (NSCLC) at earlier stages. We suspected that a parallel increase in early detection and resection of small cell lung cancer (SCLC) was also occurring. We therefore reviewed our institutional experience to explore trends in surgically resected SCLC frequency and outcomes. Methods: A single-institution, retrospective review was performed of all SCLC cases resected between 2000–2022. We evaluated demographics, oncologic characteristics, overall survival (OS), and disease-free survival (DFS). Results: Among 30 patients with resected SCLC, the majority underwent lobectomy (73%) and only 37% were known to have SCLC preoperatively. The frequency of resections increased over time with almost half (47%) occurring in the last four study years (2019–2022). This increase in SCLC resections coincided with increasing lung cancer screening (LCS) volume, with no change in thoracic surgical case volume. The 2019–2022 cohort was predominantly clinical stage I (86%) compared to 56% pre-2019 (I vs. II–IV, P=0.08), and also trended toward more screen-detected (43% vs. 13%, P=0.08) patients. Subgroup analysis showed encouraging OS outcomes following surgical resection for clinical and pathological stage I patients. There was a trend toward better OS among screen-detected patients (73% vs. 34%, log-rank P=0.07) that was significant in DFS (75% vs. 26%, P=0.02). Conclusions: The number of surgically resected SCLC patients at our institution has increased in recent years, as has the proportion of screen-detected and clinical stage I cases, alongside rising LCS volume. This may be an early signal of a broader trend toward increasing diagnosis of limited stage SCLC eligible for resection.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Increased rates of surgical resection of early-stage small cell lung cancer in a single-institution cohort
Date Crossref
01/06/2026
Éditeur
AME Publishing Company
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Lung Cancer Research StudiesLung Cancer Diagnosis and TreatmentLung Cancer Treatments and Mutations

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.